SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000947871-16-001363
Filing Date
2016-07-26
Accepted
2016-07-26 16:15:12
Documents
2
Group Members
ORBIMED CAPITAL GP IV LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 8 ss4294_sc13da.htm SC 13D/A 146903
2 JOINT FILING AGREEMENT ss4294_ex9901.htm EX-99.1 18440
  Complete submission text file 0000947871-16-001363.txt   166826
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 650-421-9500
Relypsa Inc (Subject) CIK: 0001416792 (see all company filings)

IRS No.: 260893742 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87732 | Film No.: 161784533
SIC: 2834 Pharmaceutical Preparations